Medical Device Reimbursement Rewards Reps Who Know the Code Before the Surgeon Asks

Medical device reimbursement is the payment a hospital or physician receives from an insurer for the procedure your device is used in, tied to a specific billing code. A device doesn't get adopted on clinical merit alone.

It gets adopted when the person selling it can explain exactly what the hospital gets paid, and what it costs them to say yes.

Key Takeaways

• Mark Copeland says knowing your reimbursement codes puts you a step ahead of 90% of other reps, in his experience, because most never bother to look them up.
• Copeland uses a total knee procedure's $113,000 reimbursement code as his go-to example of the math a rep should be able to cite cold.
• Contribution margin, not just topline revenue, is the term a value analysis committee uses to judge a new device.
• Reimbursement codes for a genuinely new technology can take five years or longer to establish, which changes how founders should plan a launch timeline.
• A rep's job includes knowing what a surgeon's current volume reimburses today and what the new product reimburses, side by side.

Watch the full episode on YouTube

Knowing the Reimbursement Code Separates the Top 10% of Reps

Medical device reimbursement starts with a billing code, and most reps in the field never bother to learn the ones tied to their own product.

I interviewed Mark Copeland on an episode about selling to the hospital value analysis committee. He named the gap directly:

"Know your codes. If you sell something into an OR or a doctor's office, know the codes and have a sense of how much they get compensated on that, and the hospital gets compensated. It's googleable. It's not hard. So if you do that, you're a step ahead of 90% of the other reps."

That's a low bar by design. Copeland's point is that almost nobody looks, even though the codes are easy to find, so the few who do walk into the room already ahead of the conversation.

How a Single Reimbursement Code Can Carry Millions in Hospital Revenue

A reimbursement code is the number that tells a hospital whether a procedure is worth doing more of, and that math is exactly what a value analysis committee wants to see.

Copeland walked through a concrete example on the same episode, addressing a scenario most reps get wrong:

"If it's a total knee, that's $3.3 million of topline revenue, because the code is at least $113,000 for reimbursement for a hospital outpatient surgery procedure. And when you say that to a surgeon, and you say, oh, by the way, even on that $113,000 they make a high contribution margin on their total joints, that surgeon goes, what's contribution margin?"

Most reps pitch a faster procedure as a scheduling win, where one more case fits in the day.

Copeland's reframe turns that same fact into a revenue number a hospital administrator tracks, and contribution margin is the term that gets a value analysis committee to lean in rather than tune out.

Contribution Margin Matters More Than Topline Revenue in These Conversations

A value analysis committee evaluates a new device on contribution margin, the profit left after the direct cost of the procedure, rather than on topline revenue, and most reps never learn to speak in that term.

Copeland described why that specific vocabulary matters:

"It's profit, but it's the smart term the value analysis team uses. So say that, and all of a sudden the surgeon is more armed to present something that they want."

A surgeon who wants a new device still has to sell it internally to the committee that controls the budget. Give that surgeon the term the committee uses, and the surgeon becomes a credible internal advocate instead of someone pushing a personal preference.

Reimbursement Codes for New Technology Can Take Years to Establish

Medical device reimbursement isn't always available on day one. When a technology is new enough that no existing code fits it, founders can be years away from the number that makes their product commercially viable.

I interviewed Mike Karim, cofounder of Oxford Endovascular, on an episode about spinning out university medtech innovations. He described the timeline founders consistently underestimate:

"To get reimbursement codes for technology that just isn't reimbursed, that can add another five years to the journey to get anywhere near commercialization, or even longer."

Founders who build a launch plan assuming reimbursement exists from day one are planning around a number that may not show up for half a decade.

Factoring that timeline into the business plan from the start is cheaper than discovering it after the capital is already spent.

What This Means for Medtech Founders

In my experience working with medtech founders, reimbursement gets treated as a finance-team problem instead of a sales problem, and that's backward.

Every rep representing your device should be able to state the exact code, the dollar figure behind it, and the contribution margin a hospital earns from it, the same way Copeland described. A value analysis committee engages with that pitch instead of tuning it out.

And if your technology doesn't have an established code yet, that gap belongs in the commercial timeline next to the regulatory one.

How market engineering changes what medical device sales requires covers the rest of what a rep needs beyond the reimbursement math.

Frequently Asked Questions

What is medical device reimbursement?

Medical device reimbursement is the payment an insurer makes to a hospital or physician for a procedure that uses the device, tied to a specific billing code.

The code determines both the payment amount and whether a procedure is financially viable for a hospital to perform.

How does medical device reimbursement work?

A procedure gets assigned a billing code that insurers use to pay the hospital or physician a set amount.

Reps and founders who know that code and the contribution margin behind it can make a far stronger case to a hospital's value analysis committee than those who only pitch clinical benefits.

Why do new medical devices sometimes lack a reimbursement code?

A genuinely new technology can fall outside every existing billing code, and establishing a new code through the payer system can take five years or longer. Founders need to plan for that timeline separately from the regulatory clearance timeline.

What does a hospital value analysis committee look for in reimbursement?

A value analysis committee looks at contribution margin, the profit left after direct procedure costs, rather than topline revenue alone. A rep who can speak in that specific term gives the surgeon sponsoring the device a stronger internal case to make.

Where to Go From Here

If you're doing this yourself. Read the five pillars of market engineering to see how reimbursement strategy fits into the broader commercial sequence before a product ever reaches a value analysis committee.

If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For founders building a launch plan, the audit flags where reimbursement timing should sit in the sequence.

Listen to the Full Conversations

• Secrets to Selling to the Hospital Value Analysis Committee with Mark Copeland
• How to Spinout University Innovations with Mike Karim, Cofounder of Oxford Endovascular

Subscribe wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth.

Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.